Gnetin C displayed substantial inhibitory effects in prostate cancer cells expressing MTA1, while in MTA1 knockdown cells, Gnetin C showed partial MTA1-independent mechanisms that inhibit cell metastatic potential and induce apoptosis. Here, MTA1 is linked to prostate carcinoma.